0 Yorumlar
0 hisse senetleri
814 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Experts Warn of Disease Gaps While Ivermectin Gains BuzzAs public health experts raise alarms over critical gaps in disease preparedness, Ivermectin has emerged at the center of national healthcare debates. With concerns about the CDC’s capacity to manage outbreaks, questions around public trust, and the balance between prevention and treatment, the drug has regained visibility in policy discussions and research priorities. The...0 Yorumlar 0 hisse senetleri 16 Views 0 önizleme
-
Why Are American Patients Choosing Ivermectin Over Paxlovid in 2025?In 2025, the landscape of COVID-19 treatment options in the United States continues to evolve. While Paxlovid has been widely prescribed since its emergency authorization, a significant number of American patients are increasingly choosing Ivermectin for COVID-19 instead. This shift in preference is driven by various factors including perceptions of safety, cost considerations,...0 Yorumlar 0 hisse senetleri 974 Views 0 önizleme